Table 1 Baseline characteristics of patients with end stage renal disease who received CTO PCI.
From: Revascularization of coronary chronic total occlusion in patients with end stage renal disease
Success (n = 163) | Fail (n = 53) | P value | |
|---|---|---|---|
Age, years | 71 ± 12 | 70 ± 14 | 0.576 |
Male gender, % | 136 (83) | 39 (74) | 0.157 |
HT, % | 142 (87) | 47 (89) | 1.000 |
DM, % | 99 (61) | 32 (60) | 1.000 |
Dyslipidemia, % | 56 (34) | 21 (40) | 0.512 |
Prior stroke, % | 24 (15) | 7 (13) | 1.000 |
Prior CABG, % | 16 (10) | 5 (9) | 1.000 |
HF, % | 63 (39) | 23 (43) | 0.628 |
AF, % | 12 (12) | 5 (18) | 0.528 |
PAD, % | 22 (14) | 15 (28) | 0.020 |
Smoking, % | |||
LDL, U/L | 86 ± 35 | 86 ± 35 | 0.992 |
Hb, g/dl | 10.5 ± 1.8 | 10.3 ± 1.5 | 0.450 |
LVEF, % | 45 ± 13 | 40 ± 14 | 0.060 |
Medications | |||
Statin | 45 (28) | 15 (28) | 1.000 |
ARB | 32 (20) | 15 (28) | 0.186 |
Beta blocker | 65 (40) | 16 (30) | 0.253 |
